SaferSkin™ Launched at SOT

SaferSkin™
- integrated skin sensitisation assessment

An estimated 15-20% of the general population suffers from allergic contact dermatitis, or skin sensitisation. In fact, skin sensitisation is considered the most prevalent form of immunotoxicity found in humans, responsible for over seven million outpatient visits annually.*

SaferSkin™ is an easy-to-use software application which helps you determine, with confidence, the skin sensitisation potency of a substance according to accepted OECD guidelines. Applying three different and well-accepted scientific approaches, SaferSkin™ assesses input data, assigns a sensitisation category and calculates the level of confidence in the prediction. In one step, SaferSkin™ can help you make the best decisions in line with regulatory guidelines and best industry practices. SaferSkin™ supports the principles of the 3Rs of animal testing (Reduction, Refinement, Replacement) for more humane research.

Openness and transparency is in our company’s DNA so the SaferSkin™ Basic version is free and available to the global community. SaferSkin™ Professional offers additional and more advanced features at an affordable rate. The Enterprise version offers you the opportunity to define features for SaferSkin™ that are customised to your specific needs.

SaferSkin™ is the first of a range of chemical safety applications we have in the pipeline.

 

Get in touch for a free trial, or visit https://saferworldbydesign.com/saferskin/

 


* Kimber I, Basketter DA, Gerberick GF, Dearman RJ (2002). "Allergic contact dermatitis". Int. Immunopharmacol. 2 (2–3): 201–11. doi:10.1016/S1567-5769(01)00173-4. PMID 11811925

About Edelweiss Connect

Edelweiss Connect manages collaborative projects to achieve goals in scientific research, infrastructure development or service provision. Effective collaboration requires many elements including coordination, culture, communications, common understanding, decision-making and interoperability.

Tags

Latest Tweets

Edelweiss Connect (2 weeks ago)
Edelweiss Connect at front of the move to non-animal testing with SaferSkin™ https://t.co/CLqvbKP6Xj #AnimalTesting… https://t.co/K2uQcj6qw7
Edelweiss Connect (2 weeks ago)
@UniLeiden Bob van de Water leads EU-ToxRisk. Aiming for paradigm shift in toxicological testing: reliable, animal-… https://t.co/DNekLz31pX
Edelweiss Connect (2 weeks ago)
#eutoxrisk Bob van de Water: "10 case studies, different partners in different disciplines, all generating data! Ed… https://t.co/FxP9IQwWSQ
Edelweiss Connect (2 weeks ago)
Prof Bob van de Water, coordinator of EU-ToxRisk, largest EU programme in toxicology. 39 partner organisations acro… https://t.co/3obHsS2mCv
Edelweiss Connect (2 weeks ago)
@UniLeiden spin-off develops 50+ cell lines “reporting” stress response signaling toxicity. Genetically-engineered… https://t.co/xSa4JZsGOA

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 851 0170
  • Email: info@edelweissconnect.com